Singapore: US based Irvine Pharmaceutical Services, a contract manufacturing service provider, plans to open a new facility in Hangzhou, China to support the Asian market.

The 115,000 sqft facility is scheduled to be fully operational in the first quarter of 2015. Dr Assad J Kazeminy, CEO and founder of the company said, "Irvine is responding to the rising needs of large multi-national pharmaceutical companies that are looking for contract organizations overseas that include robust cGMP quality infrastructure and technical expertise. Irvine will now have a local presence and a strong understanding of the local market to offer the region high quality analytical support."